Pharmaceutical preparations and components thereof for treatment of infectious disease, namely, QTY-code designed cytokine and chemokine receptor protein variants with antibody-like properties used to trap cytokines, chemokines and inflammatory mediators released by immune effector cells during pathophysiological conditions, including but not limited to cytokine release syndrome associated with CAR-T therapy, Coronavirus-induced lung damage, and other such similar pathophysiological conditions

'antibodi':24 'antibody-lik':23 'associ':51 'car':54 'car-t':53 'cell':39 'chemokin':18,31 'code':14 'compon':4 'condit':42,67 'coronavirus':58 'coronavirus-induc':57 'cytokin':16,30,48 'damag':61 'design':15 'diseas':10 'effector':38 'immun':37 'includ':43 'induc':59 'infecti':9 'inflammatori':33 'like':25 'limit':46 'lung':60 'mediat':34 'name':11 'pathophysiolog':41,66 'pharmaceut':1 'prepar':2 'properti':26 'protein':20 'qti':13 'qty-cod':12 'receptor':19 'releas':35,49 'similar':65 'syndrom':50 'therapi':56 'thereof':5 'trap':29 'treatment':7 'use':27 'variant':21

AVA-TRAP

Owners

Goods & Services